Taro Pharmaceutical Industries Ltd.
Topical montelukast for treatment of atopic dermatitis

Last updated:

Abstract:

A topical formulation comprising Montelukast or a pharmaceutically acceptable salt thereof, a gelling agent and water for the treatment of atopic dermatitis.

Status:
Grant
Type:

Utility

Filling date:

3 May 2017

Issue date:

4 Feb 2020